Resproly Company
Resproly is a research and development, production and sales of formula and equipment for respiratory inhalation. An integrated enterprise that focuses on multiple clinically demanding treatment areas such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetes, and Parkinson's Disease.
Industry:
PharmTech
Headquarters:
Zhuhai, Guangdong, China
Zip:
11-50
Founded Date:
2018-01-01
Employees Number:
11-50
Acquisitions Number:
6
Investors Number:
37998390
Total Funding:
37998390
Last Funding Date:
Series B
Last Funding Type:
Series B
Register and Claim Ownership